The study is a case series of adults (males and females) presenting to a “Hair and Scalp” center in Clearwater, Florida. Subjects diagnosed with androgenetic alopecia (AGA – male pattern baldness) and who were not currently using minoxidil or finasteride, were offered the opportunity to receive a topical hemp-oil extract that is high in varins (tetrahydrocannabivarin, (THCV) cannabidivarin (CBDV)) as well as cannabidiol (CBD).
Find out more here: https://clinicaltrials.gov/ct2/show/NCT04842383